Kluge, M., H. Himmerich, P. M. Wehmeier, C. Rummel-Kluge, M. Dalal, D. Hinze-Selch, T. Kraus, R. W. Dittmann, T. Pollmächer and A. Schuld: Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine. In: Schizophrenia Research 135, 1-3, 123-127 (2012).
Dittmann, R. W., E. Meyer, F. J. Freisleder, H. Remschmidt, C. Mehler-Wex, J. Junghanss, U. Hagenah, M. Schulte-Markwort, F. Poustka, E. Schulz, M. Kluge, A. Mastele, P. M. Wehmeier and M. H. Schmidt: Olanzapine in Male and Female Adolescent Patients With Schizophrenia and Related Disorders Minor Sex Differences in Outcomes. In: Journal of Clinical Psychopharmacology 30, 3, 328-331 (2010).
Kluge, M., A. Schuld, A. Schacht, H. Himmerich, M. A. Dalal, P. M. Wehmeier, D. Hinze-Selch, T. Kraus, R. W. Dittmann and T. Pollmächer: Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. In: Psychoneuroendocrinology 34, 1, 118-128 (2009).
Kluge, M., A. Schuld, H. Himmerich, M. Dalal, A. Schacht, P. M. Wehmeier, D. Hinze-Selch, T. Kraus, R. W. Dittmann and T. Pollmächer: Clozapine and olanzapine are associated with food craving and binge eating - Results from a randomized double-blind study. In: Journal of Clinical Psychopharmacology 27, 6, 662-666 (2007).
Kluge, M., P. M. Wehmeier, R. W. Dittmann, F. Langer, J. Czekalla, M. Lehmann, F. H. Kessler, S. Beyenburg and D. Naber: A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: Changes in psychopathology and subjective well-being. In: Pharmacopsychiatry 38, 1, 6-12 (2005).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.